Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Science
Andrew Gregory Health editor

NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes

Boxes of Wegovy and Ozempic
Clinical trials found semaglutide reduces the risk of a heart attack, stroke or cardiovascular death. Photograph: Hollie Adams/Reuters

The NHS in England is to offer more than 1 million people weight-loss drugs to reduce their risk of heart attacks and strokes.

Semaglutide (Wegovy) is already available on the health service for some people living with obesity, and also offered under the brand name Ozempic to treat type 2 diabetes.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.